From the paper:
"[...] ivabradine appears to be a reasonable option for patients with POTS who have failed or are unable to tolerate other treatment options [...]"
https://www.ncbi.nlm.nih.gov/pubmed/29330767
"[...] ivabradine appears to be a reasonable option for patients with POTS who have failed or are unable to tolerate other treatment options [...]"
https://www.ncbi.nlm.nih.gov/pubmed/29330767
![ME/CFS lecture | Dr Nancy Klimas | 2011 [Chronic Fatigue Syndrome / SEID / New Zealand] - YouTube](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
